Journal of Clinical Immunology

, Volume 30, Issue 4, pp 566–573 | Cite as

Reduced CD27 Expression on Antigen-Specific CD4+ T Cells Correlates with Persistent Active Tuberculosis

  • Jing Jiang
  • Xianyuan Wang
  • Xinjing Wang
  • Zhihong Cao
  • Yanhua Liu
  • Mei Dong
  • Aihua Tong
  • Xiaoxing Cheng



CD27, a member of the tumor necrosis factor receptor family, has important role in generation of T cell immunity. In this study, association of CD27 expression on mycobacterial antigen-specific CD4+ T cells with pulmonary tuberculosis (TB) was investigated.


Mycobacterial antigen-specific CD4+ T cells were identified based on CD154 expression and CD27 expression on antigen-specific CD4 T cells was analyzed by flow cytometry.


Compared with tuberculin-positive controls, patients with bacterial culture-positive pulmonary TB had significantly reduced CD27 expression on antigen-specific CD4 T cells. The persistent active TB patients had much lower percentages of CD27+ antigen-specific CD4 T cells than culture-positive new TB patients (P = 0.008) and healthy controls (P = 0.005). Logistic regression analysis on frequencies of CD27-expressing antigen-specific CD4 T cells and TB patients’ clinical characteristics indicated that low percentage of CD27+ antigen-specific CD4 T cells correlated significantly with persistent active tuberculosis (P = 0.002, odds ratio = 19.6).


It is concluded that frequency of CD27+ antigen-specific CD4 T cells could be used as an immunological marker for persistent active TB.


CD4+ T cells CD27 tuberculosis biomarker persistent infection 



The study was supported by a grant for infectious diseases from Ministry of Health, China to XC (2008ZX10003-012), a grant from the Beijing Natural Science Foundation, China (7092100), and a grant from the Natural Science Foundation of China (30470094). The work described in the study was performed at the Division of Research, Institute of Tuberculosis, 309 Hospital, Beijing, China.


  1. 1.
    WHO. Global tuberculosis control: epidemiology, strategy, financing. 2009.Google Scholar
  2. 2.
    Korbel DS, Schneider BE, Schaible UE. Innate immunity in tuberculosis: myths and truth. Microbes Infect. 2008;10:995–1004.CrossRefPubMedGoogle Scholar
  3. 3.
    Boom WH, Canaday DH, Fulton SA, Gehring AJ, Rojas RE, Torres M. Human immunity to M. tuberculosis: T cell subsets and antigen processing. Tuberculosis (Edinb). 2003;83:98–106.CrossRefGoogle Scholar
  4. 4.
    Nolte MA, van Olffen RW, van Gisbergen KP, van Lier RA. Timing and tuning of CD27–CD70 interactions: the impact of signal strength in setting the balance between adaptive responses and immunopathology. Immunol Rev. 2009;229:216–31.CrossRefPubMedGoogle Scholar
  5. 5.
    Borst J, Hendriks J, Xiao Y. CD27 and CD70 in T cell and B cell activation. Curr Opin Immunol. 2005;17:275–81.CrossRefPubMedGoogle Scholar
  6. 6.
    Hendriks J, Gravestein LA, Tesselaar K, van Lier RA, Schumacher TN, Borst J. CD27 is required for generation and long-term maintenance of T cell immunity. Nat Immunol. 2000;1:433–40.CrossRefPubMedGoogle Scholar
  7. 7.
    Bowman MR, Crimmins MA, Yetz-Aldape J, Kriz R, Kelleher K, Herrmann S. The cloning of CD70 and its identification as the ligand for CD27. J Immunol. 1994;152:1756–61.PubMedGoogle Scholar
  8. 8.
    Hintzen RQ, Lens SM, Beckmann MP, Goodwin RG, Lynch D, van Lier RA. Characterization of the human CD27 ligand, a novel member of the TNF gene family. J Immunol. 1994;152:1762–73.PubMedGoogle Scholar
  9. 9.
    Tesselaar K, Xiao Y, Arens R, van Schijndel GM, Schuurhuis DH, Mebius RE, et al. Expression of the murine CD27 ligand CD70 in vitro and in vivo. J Immunol. 2003;170:33–40.PubMedGoogle Scholar
  10. 10.
    Akiba H, Nakano H, Nishinaka S, Shindo M, Kobata T, Atsuta M, et al. CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kappaB and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-kappaB-inducing kinase. J Biol Chem. 1998;273:13353–8.CrossRefPubMedGoogle Scholar
  11. 11.
    Arens R, Tesselaar K, Baars PA, van Schijndel GM, Hendriks J, Pals ST, et al. Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNgamma-mediated B cell depletion. Immunity. 2001;15:801–12.CrossRefPubMedGoogle Scholar
  12. 12.
    Kapina MA, Shepelkova GS, Mischenko VV, Sayles P, Bogacheva P, Winslow G, et al. CD27low CD4 T lymphocytes that accumulate in the mouse lungs during mycobacterial infection differentiate from CD27high precursors in situ, produce IFN-gamma, and protect the host against tuberculosis infection. J Immunol. 2007;178:976–85.PubMedGoogle Scholar
  13. 13.
    Streitz M, Tesfa L, Yildirim V, Yahyazadeh A, Ulrichs T, Lenkei R, et al. Loss of receptor on tuberculin-reactive T-cells marks active pulmonary tuberculosis. PLoS One. 2007;2:e735.CrossRefPubMedGoogle Scholar
  14. 14.
    Chattopadhyay PK, Yu J, Roederer M. A live-cell assay to detect antigen-specific CD4+ T cells with diverse cytokine profiles. Nat Med. 2005;11:1113–7.CrossRefPubMedGoogle Scholar
  15. 15.
    Frentsch M, Arbach O, Kirchhoff D, Moewes B, Worm M, Rothe M, et al. Direct access to CD4+ T cells specific for defined antigens according to CD154 expression. Nat Med. 2005;11:1118–24.CrossRefPubMedGoogle Scholar
  16. 16.
    Kirchhoff D, Frentsch M, Leclerk P, Bumann D, Rausch S, Hartmann S, et al. Identification and isolation of murine antigen-reactive T cells according to CD154 expression. Eur J Immunol. 2007;37:2370–7.CrossRefPubMedGoogle Scholar
  17. 17.
    Wang X, Cao Z, Jiang J, Niu H, Dong M, Tong A, et al. Association of mycobacterial antigen-specific CD4(+) memory T cell subsets with outcome of pulmonary tuberculosis. J Infect. 2010;60:133–9.CrossRefPubMedGoogle Scholar
  18. 18.
    Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol. 1984;133:1710–5.PubMedGoogle Scholar
  19. 19.
    Wallis RS, Doherty TM, Onyebujoh P, Vahedi M, Laang H, Olesen O, et al. Biomarkers for tuberculosis disease activity, cure, and relapse. Lancet Infect Dis. 2009;9:162–72.CrossRefPubMedGoogle Scholar
  20. 20.
    Doherty M, Wallis RS, Zumla A. Biomarkers for tuberculosis disease status and diagnosis. Curr Opin Pulm Med. 2009;15:181–7.CrossRefPubMedGoogle Scholar
  21. 21.
    Dooms H, Abbas AK. Control of CD4+ T-cell memory by cytokines and costimulators. Immunol Rev. 2006;211:23–38.CrossRefPubMedGoogle Scholar
  22. 22.
    De Jong R, Brouwer M, Hooibrink B, Van der Pouw-Kraan T, Miedema F, Van Lier RA. The CD27- subset of peripheral blood memory CD4+ lymphocytes contains functionally differentiated T lymphocytes that develop by persistent antigenic stimulation in vivo. Eur J Immunol. 1992;22:993–9.CrossRefPubMedGoogle Scholar
  23. 23.
    Ochsenbein AF, Riddell SR, Brown M, Corey L, Baerlocher GM, Lansdorp PM, et al. CD27 expression promotes long-term survival of functional effector-memory CD8+ cytotoxic T lymphocytes in HIV-infected patients. J Exp Med. 2004;200:1407–17.CrossRefPubMedGoogle Scholar
  24. 24.
    Okada R, Kondo T, Matsuki F, Takata H, Takiguchi M. Phenotypic classification of human CD4+ T cell subsets and their differentiation. Int Immunol. 2008;20:1189–99.CrossRefPubMedGoogle Scholar
  25. 25.
    Rutishauser RL, Martins GA, Kalachikov S, Chandele A, Parish IA, Meffre E, et al. Transcriptional repressor Blimp-1 promotes CD8(+) T cell terminal differentiation and represses the acquisition of central memory T cell properties. Immunity. 2009;31:296–308.CrossRefPubMedGoogle Scholar
  26. 26.
    Hamann D, Baars PA, Rep MH, Hooibrink B, Kerkhof-Garde SR, Klein MR, et al. Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med. 1997;186:1407–18.CrossRefPubMedGoogle Scholar
  27. 27.
    Takata H, Takiguchi M. Three memory subsets of human CD8+ T cells differently expressing three cytolytic effector molecules. J Immunol. 2006;177:4330–40.PubMedGoogle Scholar
  28. 28.
    Fritsch RD, Shen X, Sims GP, Hathcock KS, Hodes RJ, Lipsky PE. Stepwise differentiation of CD4 memory T cells defined by expression of CCR7 and CD27. J Immunol. 2005;175:6489–97.PubMedGoogle Scholar
  29. 29.
    De Milito A, Aleman S, Marenzi R, Sonnerborg A, Fuchs D, Zazzi M, et al. Plasma levels of soluble CD27: a simple marker to monitor immune activation during potent antiretroviral therapy in HIV-1-infected subjects. Clin Exp Immunol. 2002;127:486–94.CrossRefPubMedGoogle Scholar
  30. 30.
    Yoshida H, Maeda T, Ishikawa J, Inoue S, Matsunaga H, Kosugi S, et al. Expression of CD27 on peripheral CD4+ T-lymphocytes correlates with the development of severe acute graft-versus-host disease after allogeneic bone marrow transplantation. Int J Hematol. 2006;84:367–76.CrossRefPubMedGoogle Scholar
  31. 31.
    Lyadova IV, Oberdorf S, Kapina MA, Apt AS, Swain SL, Sayles PC. CD4 T cells producing IFN-gamma in the lungs of mice challenged with mycobacteria express a CD27-negative phenotype. Clin Exp Immunol. 2004;138:21–9.CrossRefPubMedGoogle Scholar
  32. 32.
    Stubbe M, Vanderheyde N, Goldman M, Marchant A. Antigen-specific central memory CD4+ T lymphocytes produce multiple cytokines and proliferate in vivo in humans. J Immunol. 2006;177:8185–90.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Jing Jiang
    • 1
    • 2
  • Xianyuan Wang
    • 1
  • Xinjing Wang
    • 2
  • Zhihong Cao
    • 2
  • Yanhua Liu
    • 2
  • Mei Dong
    • 3
  • Aihua Tong
    • 3
  • Xiaoxing Cheng
    • 2
  1. 1.School of NursingThird Military Medical UniversityChongqingChina
  2. 2.Division of Research, Institute of Tuberculosis309 HospitalBeijingChina
  3. 3.Department of Laboratory Medicine309 HospitalBeijingChina

Personalised recommendations